BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16510288)

  • 1. Isoxazole-type derivatives related to combretastatin A-4, synthesis and biological evaluation.
    Kaffy J; Pontikis R; Carrez D; Croisy A; Monneret C; Florent JC
    Bioorg Med Chem; 2006 Jun; 14(12):4067-77. PubMed ID: 16510288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterocyclic and phenyl double-bond-locked combretastatin analogues possessing potent apoptosis-inducing activity in HL60 and in MDR cell lines.
    Simoni D; Grisolia G; Giannini G; Roberti M; Rondanin R; Piccagli L; Baruchello R; Rossi M; Romagnoli R; Invidiata FP; Grimaudo S; Jung MK; Hamel E; Gebbia N; Crosta L; Abbadessa V; Di Cristina A; Dusonchet L; Meli M; Tolomeo M
    J Med Chem; 2005 Feb; 48(3):723-36. PubMed ID: 15689156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel A-ring and B-ring modified combretastatin A-4 (CA-4) analogues endowed with interesting cytotoxic activity.
    Simoni D; Romagnoli R; Baruchello R; Rondanin R; Grisolia G; Eleopra M; Rizzi M; Tolomeo M; Giannini G; Alloatti D; Castorina M; Marcellini M; Pisano C
    J Med Chem; 2008 Oct; 51(19):6211-5. PubMed ID: 18783207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of vinylogous combretastatin A-4 derivatives.
    Kaffy J; Pontikis R; Florent JC; Monneret C
    Org Biomol Chem; 2005 Jul; 3(14):2657-60. PubMed ID: 15999202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of cis-locked vinylogous combretastatin-A4 analogues: derivatives with a cyclopropyl-vinyl or a cyclopropyl-amide bridge.
    Ty N; Kaffy J; Arrault A; Thoret S; Pontikis R; Dubois J; Morin-Allory L; Florent JC
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1318-22. PubMed ID: 19211248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.
    Odlo K; Hentzen J; dit Chabert JF; Ducki S; Gani OA; Sylte I; Skrede M; Flørenes VA; Hansen TV
    Bioorg Med Chem; 2008 May; 16(9):4829-38. PubMed ID: 18396050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation.
    Borrel C; Thoret S; Cachet X; Guénard D; Tillequin F; Koch M; Michel S
    Bioorg Med Chem; 2005 Jun; 13(11):3853-64. PubMed ID: 15863010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
    O'Boyle NM; Carr M; Greene LM; Bergin O; Nathwani SM; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
    J Med Chem; 2010 Dec; 53(24):8569-84. PubMed ID: 21080725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity relationships of constrained heterocyclic analogues of combretastatin A4.
    Arthuis M; Pontikis R; Chabot GG; Seguin J; Quentin L; Bourg S; Morin-Allory L; Florent JC
    ChemMedChem; 2011 Sep; 6(9):1693-705. PubMed ID: 21732536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 3,5-diaryl isoxazoline/isoxazole linked 2,3-dihydroquinazolinone hybrids as anticancer agents.
    Kamal A; Bharathi EV; Reddy JS; Ramaiah MJ; Dastagiri D; Reddy MK; Viswanath A; Reddy TL; Shaik TB; Pushpavalli SN; Bhadra MP
    Eur J Med Chem; 2011 Feb; 46(2):691-703. PubMed ID: 21194809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.
    Barrett I; Carr M; O'Boyle N; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2010 Apr; 25(2):180-94. PubMed ID: 20222762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regioselective synthesis of 3,4-diaryl-5-unsubstituted isoxazoles, analogues of natural cytostatic combretastatin A4.
    Chernysheva NB; Maksimenko AS; Andreyanov FA; Kislyi VP; Strelenko YA; Khrustalev VN; Semenova MN; Semenov VV
    Eur J Med Chem; 2018 Feb; 146():511-518. PubMed ID: 29407976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel terphenyls and 3,5-diaryl isoxazole derivatives endowed with growth supporting and antiapoptotic properties.
    Simoni D; Rondanin R; Baruchello R; Rizzi M; Grisolia G; Eleopra M; Grimaudo S; Di Cristina A; Pipitone MR; Bongiorno MR; Aricò M; Invidiata FP; Tolomeo M
    J Med Chem; 2008 Aug; 51(15):4796-803. PubMed ID: 18620379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
    J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
    Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
    Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imidazolone-amide bridges and their effects on tubulin polymerization in cis-locked vinylogous combretastatin-A4 analogues: synthesis and biological evaluation.
    Li YW; Liu J; Liu N; Shi D; Zhou XT; Lv JG; Zhu J; Zheng CH; Zhou YJ
    Bioorg Med Chem; 2011 Jun; 19(11):3579-84. PubMed ID: 21536450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4.
    Nguyen TT; Lomberget T; Tran NC; Colomb E; Nachtergaele L; Thoret S; Dubois J; Guillaume J; Abdayem R; Haftek M; Barret R
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7227-31. PubMed ID: 23063401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
    Liou JP; Chang YL; Kuo FM; Chang CW; Tseng HY; Wang CC; Yang YN; Chang JY; Lee SJ; Hsieh HP
    J Med Chem; 2004 Aug; 47(17):4247-57. PubMed ID: 15293996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.